Memory Flexibility Training for Depression

A Randomized Controlled Trial Comparing Memory Flexibility Training to Psychoeducation in the Treatment of Major Depressive Disorder

Our collection of memories for personal experiences plays an important role in shaping our sense of who we are as people. These memories, termed autobiographical memories, can also be helpful in social situations, for sharing the details of our experiences with other people, reminiscing about pleasant times and solving problems by remembering what has and hasn't worked in the past. Different types of autobiographical memory are helpful to us depending on the particular situation the investigators are in at the time. Recent research has shown that experiencing depressed mood can affect how we relate to our autobiographical memories, so that instead of providing a rich source of personal information in a helpful and flexible way, the types of memories that come to mind are more narrowly focused on difficult or negative experiences. This can cause low mood to persist over time.

The purpose of this study is to test a newly-developed therapeutic training package for depressed mood (MemFlex), designed to encourage helpful and flexible ways of relating to autobiographical memories. The MemFlex programme consists of a one-to-one orientation session with the researcher to introduce the training package, followed by a workbook that is completed at home.

Study Overview

Study Type

Interventional

Enrollment (Actual)

60

Phase

  • Phase 2
  • Phase 1

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Cambridge, United Kingdom, CB2 7EF
        • MRC Cognition and Brain Sciences Unit
      • Cambridge, United Kingdom
        • Cambridge and Peterborough NHS Foundation Trust

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Currently experiencing Major Depressive Episode, indexed on the Structured Clinical Interview for the DSM-IV (SCID; First et al., 1996).
  • Score of 13 or above on the Beck Depression Inventory (Beck et al., 1996)

Exclusion Criteria:

  • SCID assessment indicates they are experiencing another mood disorder, psychosis, current alcohol or substance dependence/abuse.
  • Diagnosed Axis II disorder or brain injury (assessed by participant report)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Memory Flexibility Training
The MemFlex programme draws on cognitive bias modification and memory specificity training techniques (Raes et al., 2009; Dalgleish et al., 2014), and was developed by clinical psychologists. MemFlex is primarily self-guided and aims to reduce autobiographical memory biases associated with depression. The training material is presented over one face-to-face session and eight self-guided sessions. In the initial session, the researcher introduces cued-recall tasks which are used throughout the workbook, and guides the participant in completion of these tasks. When understanding of the basic principles is satisfactory, the researcher assists the participant to set a schedule for completion of the workbook over the following four weeks. The participant will receive weekly emails during this period, encouraging them to complete the workbook. They will also receive a phone call from a team member at the beginning of week three to check progress.
As in experimental arm description.
Placebo Comparator: Psychoeducation
The psychoeducation condition will also complete an initial face-to-face session. This session will cover the symptoms and causes of depression, and the workbook will be introduced. As in the MemFlex condition, the workbook will consist of eight self-guided sessions that the individual will be required to complete over four weeks. The participant will receive weekly emails during this period, encouraging them to complete the workbook. They will also receive a phone call from a team member at the beginning of week three to check progress, and clarify any difficulties with the workbook material. The workbook content will cover the presentation of depression and basic information on factors associated with depression, such as worry, procrastination, and sleep difficulties. Each session consists of information on psychological theories of the topic, followed by a series of questions about the material to ensure participant engagement. The workbook was developed by clinical psychologists.
As in experimental arm description.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Depressive Status
Time Frame: Three months after completion of the workbook
Three months after completion of the workbook
Change in score on the Beck Depression Inventory (Beck, Steer, & Brown, 1996) from baseline
Time Frame: Three months after completion of the workbook
Self report measure of depression symptoms
Three months after completion of the workbook

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Depression free days
Time Frame: Three months after completion of the workbook
Number of depression free days from post to follow-up.
Three months after completion of the workbook
Change in memory flexibility from baseline, Score on the alternating instructions autobiographical memory task (Dritschel et al., 2013)
Time Frame: Three months after completion of the workbook
Score on the alternating instructions autobiographical memory task (Dritschel et al., 2013)
Three months after completion of the workbook

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Rumination as measured by Rumination Response Scale
Time Frame: 4-6 weeks after beginning the workbook
Rumination Response Scale (Treynor, Gonzalez, Nolen-Hoeksema, 2003);
4-6 weeks after beginning the workbook
Change in Cognitive Avoidance, as measured by Cognitive Avoidance Questionnaire
Time Frame: 4-6 weeks after beginning the workbook
Cognitive Avoidance Questionnaire (Sexton & Dugas, 2008)
4-6 weeks after beginning the workbook
Change in Verbal Fluency as measured by the Verbal Fluency Task
Time Frame: 4-6 weeks after beginning the workbook
Verbal Fluency Task
4-6 weeks after beginning the workbook
Change in Anxiety symptoms, as measured by the Beck Anxiety Inventory
Time Frame: 4-6 weeks after beginning the workbook
Beck Anxiety Inventory
4-6 weeks after beginning the workbook
Change in Hopelessness, as measured by Beck Hopelessness Scale
Time Frame: 4-6 weeks after beginning the workbook
Beck Hopelessness Scale
4-6 weeks after beginning the workbook
Change in Problem solving, as measured by the Means-Ends Problem Solving task
Time Frame: 4-6 weeks after beginning the workbook
Means-Ends Problem Solving task (Lyubomirsky & Nolen-Hoeksema, 2003)
4-6 weeks after beginning the workbook

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Tim Dalgleish, PhD, MRC Cognition and Brain Sciences Unit

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2015

Primary Completion (Actual)

December 1, 2016

Study Completion (Actual)

January 1, 2017

Study Registration Dates

First Submitted

February 9, 2015

First Submitted That Met QC Criteria

February 24, 2015

First Posted (Estimate)

February 25, 2015

Study Record Updates

Last Update Posted (Actual)

September 11, 2017

Last Update Submitted That Met QC Criteria

September 7, 2017

Last Verified

September 1, 2017

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Major Depressive Disorder

Clinical Trials on Memory Flexibility Training

3
Subscribe